Follow the 바텍 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바텍 has published 19 insider filings. Market capitalisation: €270.9bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨. Every trade is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Fundamental score
Ranked 787 of 29,065 companies
82.5
score / 100
Value
93
Quality
72
FCF yld18%
Earn yld15%
EV/EBITDA4.2x
ROE·
Gross mgn52%
Net mgn9.4%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
바텍 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of innovative solutions for medical diagnostics.